Apheresis Consumables and Equipment Global Market Report 2024

The apheresis consumables and equipment market size has grown rapidly in recent years. It will grow from $2.96 billion in 2023 to $3.34 billion in 2024 at a compound annual growth rate (CAGR) of 12.9%. The growth observed in the historical period can be attributed to several factors, including the escalating prevalence of chronic diseases, heightened awareness among patients regarding apheresis procedures, an increased need for various blood components, and the expanding demographic of aging populations.

The apheresis consumables and equipment market size is expected to see rapidly grown in the next few years. It will grow to $5.1 billion in 2028 at a compound annual growth rate (CAGR) of 11.1%. Anticipated growth in the forecast period is expected to stem from several factors, notably the increased application of apheresis in cell therapy, the rise of emerging infectious diseases, the evolving landscape of personalized medicine, advancements in healthcare infrastructure, a surge in blood donations, and the growing frequency of organ transplantation procedures. Key trends forecasted for this period encompass the integration of automation and robotics in apheresis technologies, the development of therapeutic apheresis methodologies, the provision of remote apheresis services, the emergence of portable apheresis equipment, and the continued emphasis on automation and robotics to enhance these processes.

Globally, the prevalence of blood disorders like sickle cell anemia, leukemia, and cancer is escalating, driving the demand for blood transfusions and apheresis equipment. Leukemia and blood cancer cases in the USA alone, projected at 60,300 annually, necessitate frequent transfusions. Similarly, sickle cell anemia affects 100,000 Americans, while 2 million carry the trait, relying on apheresis equipment for transfusions. Projections by the International Agency for Research on Cancer indicate a steep rise in cancer cases by 2040, necessitating significant blood component collections and transfusions, bolstering the apheresis consumables and equipment industry.

The surge in chronic conditions worldwide is anticipated to steer growth in the apheresis consumables and equipment market. Chronic diseases, enduring ailments without complete cures, demand ongoing management, where apheresis equipment plays a pivotal role. From autoimmune disorders to sickle cell disease and stem cell harvesting, these conditions require targeted blood component removal or collection. Projections by the National Library of Medicine indicate a substantial increase in chronic conditions among US adults, reaching 48% by 2050, driving the demand for apheresis consumables and equipment. Advancements in apheresis technology are revolutionizing blood processing, enhancing its efficiency. Innovations like automatic apheresis equipment, employing continuous flow centrifugation and customized anticoagulant infusion systems, are reshaping the industry. For instance, Haemonetics Corp's NexSys PCS, an automated apheresis equipment, has significantly boosted productivity, quality, and compliance in plasma collection centers by expediting blood separation processes.

Leading companies in the apheresis consumables and equipment sector are introducing upgraded versions to diversify therapeutic options. Fresenius Kabi's launch of the single-needle option for the Amicus Extracorporeal Photopheresis System in April 2023 exemplifies this trend. This advancement incorporates software updates for the Amicus Separator and Phelix Photoactivation Device, along with disposable kits for single or double-needle venous access. This innovation facilitates more adaptable treatment, particularly beneficial for patients with limited venous access, primarily applied in extracorporeal photopheresis for cutaneous T-cell lymphoma treatment.

Major companies operating in the apheresis consumables and equipment market include Asahi Kasei Medical Co. Ltd., Haemonetics Corporation, Kawasumi Laboratories Inc., Fresenius SE & Co. KGaA, Terumo BCT, Fenwal Inc., Braun Melsungen AG, Therakos Inc., HemaCare Corporation, Cerus Corporation, Kaneka Corporation, Nikkiso Co., Medica SpA, Terumo Corporation, Macopharma, Grifols S.A., Baxter International Inc., Fenwal, Inc., Miltenyi Biotec GmbH, Infomed SA, Lmb Technologie GmbH, Medivators Inc., Nigale Biomedical Inc., Aferetica S.r.l., Apheresis Care Group, Beijing Meso-Tech Co., Ltd., Biegler GmbH, Brightwake Ltd., Cytosorbents Corporation, DePuy Synthes Companies, Guangzhou Daji Medical Science and Technology Co., Ltd., Haier Biomedical.

North America was the largest region in the apheresis consumables and equipment market in 2023. Western Europe was the second-largest region in the global apheresis consumables and equipment market share. The regions covered in the apheresis consumables and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the apheresis consumables and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada. The apheresis consumables and equipment market consists of sales of equipment and consumables. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Within the realm of apheresis consumables and equipment, the primary products comprise disposables and specialized devices integral to apheresis technology. These consumables are specifically designed for employment in various apheresis procedures, leveraging centrifugation and membrane filtration technologies. Procedures within this domain include photopheresis, plasmapheresis, LDL apheresis, plateletpheresis, leukapheresis, erythrocytapheresis, among others. The application of apheresis consumables and equipment extends across fields such as renal disease, neurology, hematology, and various other medical domains.

The apheresis consumables and equipment market research report is one of a series of new reports provides apheresis consumables and equipment market statistics, including apheresis consumables and equipment industry global market size, regional shares, competitors with an apheresis consumables and equipment market share, detailed apheresis consumables and equipment market segments, market trend,s and opportunities, and any further data you may need to thrive in the apheresis consumables and equipment industry. This apheresis consumables and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.